54575-360 : Cantaloupe 1 g/20ml Percutaneous; Subcutaneous Injection, Solution


NDC: 54575-360
Labeler: Allergy Laboratories, Inc.
Product Type: Human Prescription Drug
Drug Name: Cantaloupe
Dosage Form: Percutaneous; Subcutaneous Injection, Solution
Application #: BLA102192
Rev. Date: 


NDC Package Codes:

  • 54575-360-02: 2 ML IN 1 VIAL, MULTI‑DOSE (54575‑360‑02)
  • 54575-360-10: 10 ML IN 1 VIAL, MULTI‑DOSE (54575‑360‑10)
  • 54575-360-30: 30 ML IN 1 VIAL, MULTI‑DOSE (54575‑360‑30)
  • 54575-360-50: 50 ML IN 1 VIAL, MULTI‑DOSE (54575‑360‑50)

Active Ingredients:

  • Cantaloupe

Dosage Strength:

  • 1 g/20mL

Pharmaceutical Classes:

  • Non-Standardized Food Allergenic Extract [EPC]
  • Increased Histamine Release [PE]
  • Cell-mediated Immunity [PE]
  • Allergens [CS]
  • Dietary Proteins [CS]
  • Fruit Proteins [EXT]

Related Products:

Based on records with the same trade name.
  • 0268-6115 Cantaloupe .1 g/ml Percutaneous Injection, Solution by Alk-abello, Inc.
  • 36987-1306 Cantaloupe .05 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-1307 Cantaloupe .05 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-1308 Cantaloupe .1 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-1309 Cantaloupe .1 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 49288-0102 Cantaloupe .05 g/ml Intradermal; Subcutaneous Injection, Solution by Antigen Laboratories, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 54575-360 QR Code

< Prev: 54575-359Next: 54575-362 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.